Effects of a Comprehensive Weight Management Program on Obese Adolescents and Children
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06520
- Yale University School Of Medicine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ages 8-16 years old
- BMI >95th percentile for age/gender based on CDC
- Both primary caregiver/parent and child must agree to participate in the nutrition classes
Exclusion Criteria:
- endocrinopathies, including hypothyroidism and diabetes
- Psychiatric disorders that will interfere with ability to complete follow-up and adherence to protocol
- Any behavioral or psychosocial issue that will interfere with subject's completion of program, including eating disorder.
- Any use of medication (steroids, for ex.) that contributes to excess adiposity.
- Any use of pharmacological intervention for weight management, including prescription medications, over-the-counter medications, or herbal supplements.
- Any concurrent membership in a weight management program.
- Inability or unwillingness of parent to accompany the child to nutrition classes.
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
weight
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
|
body mass index
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
|
% body fat
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
|
lipids
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
|
blood pressure
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
|
glucose
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
|
insulin
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
|
HOMA index
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
planned to compare dieting with non-dieting approach in weight management group
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Sonia Caprio, MD, Yale University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HIC 15994
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.